Blueshift Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,263
Closed -$177K 349
2023
Q4
$177K Buy
+12,263
New +$167K 0.09% 240
2022
Q4
Sell
-9,270
Closed -$217K 543
2022
Q3
$217K Sell
9,270
-6,329
-41% -$191K 0.05% 490
2022
Q2
$526K Buy
+15,599
New +$546K 0.09% 314
2021
Q3
Sell
-53,539
Closed -$1.62M 1216
2021
Q2
$1.62M Buy
+53,539
New +$1.76M 0.09% 253

Other funds holding OGN

Blueshift Asset Management's OGN Position: Q1 2024 in Review

Blueshift Asset Management sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 12,263 shares — an estimated $177K sold.

Blueshift Asset Management first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $1.62M in Q2 2021. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Blueshift Asset Management reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Blueshift Asset Management sold 12,263 Organon & Co shares in Q1 2024, an estimated $177K.
  • Blueshift Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Blueshift Asset Management's Organon & Co position peaked at $1.62M in Q2 2021.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Blueshift Asset Management's 13F filing for Q1 2024, filed 15 May 2024.